AstraZeneca’s Covid-19 Vaccine Found to Be 79% Effective in U.S. Study

The New York Times – Business:

The vaccine maker is preparing to apply for emergency authorization from the Food and Drug Administration. But the vaccine may not be needed in the United States.

Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.